Business Context and Reporting Period
This Form 6-K filing by Banco Bradesco S.A. (Bradesco) covers the month of April 2026. The report details the progress of a corporate reorganization aimed at consolidating the healthcare businesses of the Bradesco Organization into Odontoprev S.A. (Odontoprev).
Key Financial Metrics
The filing text does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity figures. The document focuses exclusively on corporate governance and transactional updates regarding the healthcare business consolidation.
Material Changes and Transaction Status
- Shareholder Approval: Extraordinary General Shareholders' Meetings for Odontoprev and Bradesco Gestão de Saúde S.A. (BGS) were held and approved the merger of BGS shares by Odontoprev and the contribution of operating assets and liabilities of Odontoprev to Mediservice Operadora de Planos de Saúde S.A. (Mediservice).
- Regulatory Approvals: All conditions precedent were satisfied, including authorization from the National Supplementary Health Agency (ANS) on March 30, 2026, for the Merger of Shares, and on April 2, 2026, for the Asset Contribution.
- Effective Date: Subject to Board of Directors ratification, the Merger of Shares is scheduled to become effective on April 30, 2026.
- Dissenting Shareholders: The transaction proceeds prior to the expiration of the withdrawal right period, with the Board of Directors of Odontoprev waiving reconsideration of the transaction due to the exercise of withdrawal rights by dissenting shareholders.
Guidance, Outlook, and Risks
Bradesco commits to keeping shareholders and the market informed of material developments regarding the transaction. The filing includes a standard forward-looking statements disclaimer, noting that future results depend on economic conditions, industry trends, and operating factors, and that actual results may differ materially from current expectations.
Investor Verification Checklist
- Confirm the final ratification of the transaction by the Boards of Directors of Odontoprev and BGS.
- Verify the official effective date of the Merger of Shares on April 30, 2026.
- Monitor subsequent disclosures for details on the financial impact of the asset contribution to Mediservice.
- Review Odontoprev's separate disclosures for further details on the transaction structure.